Oasmia Pharmaceutical AB Company Profile | StatInvestor

Health Care & Life Sciences » Biotechnology | Oasmia Pharmaceutical AB

Oasmia Pharmaceutical AB

Oasmia Pharmaceutical AB
Stock Exchange	Frankfurt Stock Exchange
EPS	EUR0.08
Market Cap	EUR186.22 M
Shares Outstanding	176.54 M
Public Float	-

Oasmia Pharmaceutical AB ADR
Stock Exchange	NASDAQ Stock Market
EPS	$0.29
Market Cap	$150.68 M
Shares Outstanding	74.97 M
Public Float	-

Oasmia Pharmaceutical AB
Stock Exchange	OTC Publication Venue
EPS	SEK0.87
Market Cap	SEK1.53 B
Shares Outstanding	224.9 M
Public Float	132.86 M

Profile

Address	Vallongatan 1 Uppsala UP 752 28 Sweden
Employees	-
Website	http://www.oasmia.com
Updated	07/08/2019
Oasmia Pharmaceutical AB engages in the research and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. The company was founded by Julian Aleksov and Bo Cederstrand on April 15, 1988 and is headquartered in Uppsala, Sweden.

Financials

Julian Aleksov

Chairman

Alexander Kotsinas

Non-Executive Director